申请人:Chugai Seiyaku
Kabushiki Kaisha
公开号:EP0515684A1
公开(公告)日:1992-12-02
A pharmaceutical composition containing as the active ingredient a compound which presents low-density lipoproteins (LDL) represented by the compounds of formula (I) from being negatively charged. This composition inhibits the LDL from undergoing denaturation (oxidation) necessary for the recognition by a scavenger acceptor, and is used for treating arteriosclerosis, peptic ulcer, cancer, ischemic organ disease, inflammation and pulmonary silicosis.
一种药物组合物,其活性成分是一种能使以式(I)化合物为代表的低密度脂蛋白(LDL)不带负电荷的化合物。这种组合物能抑制低密度脂蛋白发生清道夫接受体识别所需的变性(氧化),用于治疗动脉硬化、消化性溃疡、癌症、缺血性器官疾病、炎症和肺矽肺。